Evidence map›Paper›PMID 22646736›Full record

ArticleAIDS care2013

Reliability and validity of the Functional Assessment of Human Immunodeficiency Virus Infection (FAHI) in patients with drug and alcohol use disorders.

Shannon Byrne, Nancy M Petry

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in AIDS care, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Shannon ByrneCalhoun Cardiology Center, University of Connecticut Health Center, Farmington, CT, USA.
Nancy M Petry

Funding

TSF to enhance treatment of cocaine dependenceP50DA009241 · NIDA · YALE UNIVERSITY · PI CARROLL, KATHLEEN M. · 1994 to 2018
$40.5M
ZONISAMIDE VERSUS PLACEBOM01RR006192 · NCRR · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI DRAZINIC, CAROLYN M · 1994 to 2008
$22.1M
Vulnerabilities for coping-related drinking among post-college young adultsP60AA003510 · NIAAA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI HESSELBROCK, VICTOR M · 2008 to 2017
$17.5M
VOUCHERS VS PRIZES--CONTINGENCY MANAGEMENTR01DA013444 · NIDA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI ALESSI, SHEILA MARIE · 2000 to 2015
$6.2M
POST-DOCTORAL TRAINING PROGRAM IN ALCOHOL STUDIEST32AA007290 · NIAAA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI SHEILA MARIE ALESSI · 1985 to 2026
$3.2M
Reinforcing Exercise in Cocaine AbusersR01DA027615 · NIDA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI PETRY, NANCY M · 2009 to 2013
$3.2M
Contingency Management for Initiating Smoking AbstinenceR01DA024667 · NIDA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI WHITE, WILLIAM BARRY · 2008 to 2012
$2.8M
Group-Based Contingency Management/Outpatient TreatmentR01DA018883 · NIDA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI PETRY, NANCY M · 2004 to 2008
$2.0M
Recovery Enhancement With Awards Enhancement With Awards Research Dissemination (P30DA023918 · NIDA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI PETRY, NANCY M · 2009 to 2010
$1.8M
Training Therapists to Administer Contingency ManagementR01DA016855 · NIDA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI PETRY, NANCY M · 2003 to 2007
$1.8M
Lower-Cost Contingency Management in a Group SettingR01DA014618 · NIDA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI PETRY, NANCY M · 2002 to 2005
$1.4M
Healthy Activities for Prize Incentives (HAPI)R01DA022739 · NIDA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI PETRY, NANCY M · 2008 to 2012
$1.3M
NCRR NIH HHS M01 RR006192NCRR NIH HHS M01-RR06192NIAAA NIH HHS P60 AA003510NIAAA NIH HHS P60-AA03510NIAAA NIH HHS T32 AA007290NIAAA NIH HHS T32-AA07290NIDA NIH HHS P30 DA023918NIDA NIH HHS P30-DA023918NIDA NIH HHS P50 DA009241NIDA NIH HHS P50-DA09241NIDA NIH HHS R01 DA013444NIDA NIH HHS R01 DA016855NIDA NIH HHS R01-DA016855NIDA NIH HHS R01 DA018883NIDA NIH HHS R01-DA018883NIDA NIH HHS R01 DA022739NIDA NIH HHS R01-DA022739NIDA NIH HHS R01-DA024667NIDA NIH HHS R01 DA027615NIDA NIH HHS R01-DA027615NIDA NIH HHS R01-DA13444NIDA NIH HHS R01-DA14618
6 · The paper itself

Abstract

Human Immunodeficiency Virus (HIV) and substance use disorders can both significantly impact a patient's quality of life (QOL), and it is, therefore, important to assess QOL throughout treatments for these chronic conditions. This study evaluated the psychometric properties of the Functional Assessment of Human Immunodeficiency Virus Infection (FAHI) in 170 HIV-positive patients who participated in a substance abuse treatment study. Internal consistency of the FAHI was good. Convergent and discriminant validity were generally supported with comparisons to other patient-reported measures. FAHI scores were not significantly associated with viral loads or CD4 counts, and they were similar in patients with and without AIDS. Patients who achieved longer durations of drug and alcohol abstinence during treatment reported better QOL post-treatment. The FAHI appears to be a reliable and valid measure for assessing QOL in HIV-positive patients with concurrent drug and alcohol use disorders.

Indexed as

Health Status IndicatorsAdultCD4 Lymphocyte CountFemaleHIV InfectionsHumansMaleMiddle AgedMultivariate AnalysisPatientsPsychometricsQuality of LifeReproducibility of ResultsSubstance-Related DisordersSurveys and QuestionnairesViral Load

Identifiers

PMID22646736
PMCPMC3478433

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.